View More Recent Stories

Jan 2, 2025 10:56AM Stifel Highlights Iovanace Biotherapeutics (IOVA) as 'Top Pick' in Biotech's 2025 Outlook Note
Jan 2, 2025 06:35AM Oppenheimer Reiterates Outperform Rating on Jasper Therapeutics (JSPR)
Dec 5, 2024 04:06PM BMO Capital Starts Jasper Therapeutics (JSPR) at Outperform
Oct 15, 2024 06:35AM H.C. Wainwright Reiterates Buy Rating on Jasper Therapeutics (JSPR)
Oct 14, 2024 02:27PM Oppenheimer Reiterates Outperform Rating on Jasper Therapeutics (JSPR)
Oct 14, 2024 02:25PM BTIG Reiterates Buy Rating on Jasper Therapeutics (JSPR)
Oct 14, 2024 02:17PM TD Cowen Reiterates Buy Rating on Jasper Therapeutics (JSPR)
Oct 14, 2024 07:01AM Jasper Therapeutics (JSPR) Reports Positive Data from SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria
Sep 30, 2024 07:22AM Oppenheimer Reiterates Outperform Rating on Jasper Therapeutics (JSPR)
Sep 10, 2024 07:31AM Jasper Therapeutics (JSPR) Announces Health Canada Clearance of Clinical Trial Application for Phase 1b/2a Study of Briquilimab in Asthma
Sep 9, 2024 03:35AM JMP Securities Starts Jasper Therapeutics (JSPR) at Market Outperform
Aug 14, 2024 06:48AM H.C. Wainwright Reiterates Buy Rating on Jasper Therapeutics (JSPR)
Aug 14, 2024 06:25AM Jasper Therapeutics (JSPR) PT Lowered to $68 at RBC Capital
Aug 13, 2024 07:53AM Jasper Therapeutics (JSPR) Tops Q2 EPS by 12c
Jul 10, 2024 07:38AM TD Cowen Reiterates Buy Rating on Jasper Therapeutics (JSPR)
Jul 9, 2024 07:00PM 2Q24 U.S. biotech earnings preview
Jul 8, 2024 06:09AM BTIG Starts Jasper Therapeutics (JSPR) at Buy
Jun 26, 2024 04:06PM Stifel Starts Jasper Therapeutics (JSPR) at Buy
Jun 25, 2024 03:27PM Oppenheimer Reiterates Outperform Rating on Jasper Therapeutics (JSPR)
View More Recent Stories